Cerebrospinal Fluid and Blood Cytokines as Biomarkers for Multiple Sclerosis: A Systematic Review and Meta-Analysis of 226 Studies With 13,526 Multiple Sclerosis Patients
Background: Multiple sclerosis (MS) biomarker identification is important for pathogenesis research and diagnosis in routine clinical practice. Cerebrospinal fluid (CSF) and blood cytokines as potential biomarkers that can inform MS pathogenesis, diagnosis and response to treatment have been assesse...
Main Authors: | Zhile Bai, Duanduan Chen, Luyao Wang, Yu Zhao, Tiantian Liu, Yun Yu, Tianyi Yan, Yong Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-10-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnins.2019.01026/full |
Similar Items
-
Cerebrospinal fluid in multiple sclerosis
by: Rammohan Kottil
Published: (2009-01-01) -
Cerebrospinal fluid biomarkers in multiple sclerosis
by: Hayrettin Tumani, et al.
Published: (2009-08-01) -
The Cerebrospinal Fluid in Multiple Sclerosis
by: Florian Deisenhammer, et al.
Published: (2019-04-01) -
Elevated Levels of Proinflammatory Cytokines in Cerebrospinal Fluid of Multiple Sclerosis Patients
by: Timur Khaibullin, et al.
Published: (2017-05-01) -
Cerebrospinal Fluid Analysis in Multiple Sclerosis Diagnosis: An Update
by: Bruna Lo Sasso, et al.
Published: (2019-06-01)